prednisolone has been researched along with Critical Illness in 10 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Critical Illness: A disease or state in which death is possible or imminent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conducted a multi-center cohort study of children in Turkish Pediatric Intensive Care units with hyperferritinemia associated secondary HLH/sepsis/MODS/MAS treated with less immunosuppression (plasma exchange and intravenous immunoglobulin or methyl prednisolone) or with the primary HLH protocol (plasma exchange and dexamethasone or cyclosporine A and/or etoposide)." | 3.78 | Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment? ( Bayrakci, B; Carcillo, JA; Citak, A; Demirkol, D; Dursun, O; Erkek, N; Gedik, H; Karabocuoglu, M; Karapinar, B; Kendirli, T; Kesici, S; Koroglu, TF; Yildizdas, D, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q | 1 |
| Yang, Q | 1 |
| Fang, Y | 1 |
| Chen, G | 1 |
| Lv, X | 1 |
| Akkad, H | 1 |
| Cacciani, N | 1 |
| Llano-Diez, M | 1 |
| Corpeno Kalamgi, R | 1 |
| Tchkonia, T | 1 |
| Kirkland, JL | 1 |
| Larsson, L | 1 |
| Park, DW | 1 |
| Kim, TH | 1 |
| Shon, JW | 1 |
| Yoon, HJ | 1 |
| Park, SS | 1 |
| Jeon, SC | 1 |
| Choi, YW | 1 |
| Paik, SS | 1 |
| Kim, H | 1 |
| Lee, Y | 1 |
| Jung, HS | 1 |
| Choi, HJ | 1 |
| Kim, MJ | 1 |
| Kim, TM | 1 |
| Park, KS | 1 |
| Kim, SY | 1 |
| Kuroda, T | 1 |
| Kumagai, M | 1 |
| Nosaka, S | 1 |
| Nakazawa, A | 1 |
| Takimoto, T | 1 |
| Hoshino, K | 1 |
| Martin, C | 1 |
| Steinke, T | 1 |
| Bucher, M | 1 |
| Raspé, C | 1 |
| Demirkol, D | 1 |
| Yildizdas, D | 1 |
| Bayrakci, B | 1 |
| Karapinar, B | 1 |
| Kendirli, T | 1 |
| Koroglu, TF | 1 |
| Dursun, O | 1 |
| Erkek, N | 1 |
| Gedik, H | 1 |
| Citak, A | 1 |
| Kesici, S | 1 |
| Karabocuoglu, M | 1 |
| Carcillo, JA | 1 |
| Rice, P | 1 |
| Simmons, K | 1 |
| Carr, R | 1 |
| Banatvala, J | 1 |
| Maddison, PJ | 1 |
| Thorpe, C | 1 |
| Seale, JR | 1 |
| Ahmed, W | 1 |
| Whiteley, GS | 1 |
| Williams, FM | 1 |
| Chinn, S | 1 |
| Hughes, GR | 1 |
| Leach, RM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II Open-Label, Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of Vamorolone in Boys Ages 2 to <4 Years and 7 to <18 Years With Duchenne Muscular Dystrophy (DMD)[NCT05185622] | Phase 2 | 54 participants (Anticipated) | Interventional | 2022-03-21 | Recruiting | ||
| A Phase II Pilot Trial of Vamorolone vs. Placebo for the Treatment of Becker Muscular Dystrophy[NCT05166109] | Phase 2 | 39 participants (Anticipated) | Interventional | 2022-07-07 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 other studies available for prednisolone and Critical Illness
| Article | Year |
|---|---|
Potential benefits of precise corticosteroid therapy for critical COVID-19.
Topics: Adrenal Cortex Hormones; Aged; C-Reactive Protein; COVID-19; COVID-19 Drug Treatment; Critical Illne | 2022 |
Vamorolone treatment improves skeletal muscle outcome in a critical illness myopathy rat model.
Topics: Animals; Anti-Inflammatory Agents; Contractile Proteins; Critical Illness; Cytokines; Disease Models | 2019 |
Vamorolone treatment improves skeletal muscle outcome in a critical illness myopathy rat model.
Topics: Animals; Anti-Inflammatory Agents; Contractile Proteins; Critical Illness; Cytokines; Disease Models | 2019 |
Vamorolone treatment improves skeletal muscle outcome in a critical illness myopathy rat model.
Topics: Animals; Anti-Inflammatory Agents; Contractile Proteins; Critical Illness; Cytokines; Disease Models | 2019 |
Vamorolone treatment improves skeletal muscle outcome in a critical illness myopathy rat model.
Topics: Animals; Anti-Inflammatory Agents; Contractile Proteins; Critical Illness; Cytokines; Disease Models | 2019 |
Near fatal desquamative interstitial pneumonia with bilateral recurrent tension pneumothorax.
Topics: Adult; Biopsy, Needle; Clarithromycin; Combined Modality Therapy; Critical Illness; Disease Progress | 2015 |
Life-threatening hypoglycemia induced by a tyrosine kinase inhibitor in a patient with neuroendocrine tumor: a case report.
Topics: Adult; Antineoplastic Agents; Critical Care; Critical Illness; Humans; Hypoglycemia; Indoles; Male; | 2011 |
Critical infantile hepatic hemangioma: results of a nationwide survey by the Japanese Infantile Hepatic Hemangioma Study Group.
Topics: Adrenergic beta-Antagonists; Antineoplastic Agents; Blood Coagulation Disorders; Cardiac Output, Hig | 2011 |
[Perioperative Addisonian crisis].
Topics: Addison Disease; Adrenal Cortex Function Tests; Adult; Anesthesia; Anti-Inflammatory Agents; Blood V | 2012 |
Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Combined Modality Therapy; C | 2012 |
Near fatal chickenpox during prednisolone treatment.
Topics: Adult; Chickenpox; Critical Care; Critical Illness; Disease Susceptibility; Female; Humans; Immunity | 1994 |
'Catastrophic' antiphospholipid syndrome.
Topics: Anti-Inflammatory Agents; Anticoagulants; Antiphospholipid Syndrome; Antirheumatic Agents; Critical | 2000 |
Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome.
Topics: Adolescent; Adult; Age Factors; Age of Onset; Aged; Antiphospholipid Syndrome; Child; Critical Care; | 2002 |